Stockscreener 앱 받기
38.98
2.53%
-0.955
전일 마감가:
$39.94
열려 있는:
$39.32
하루 거래량:
77,441
Relative Volume:
0.11
시가총액:
$699.92M
수익:
$116.88M
순이익/손실:
$-25.09M
주가수익비율:
-278.46
EPS:
-0.14
순현금흐름:
$-20.74M
1주 성능:
+7.78%
1개월 성능:
+45.10%
6개월 성능:
+112.85%
1년 성능:
+42.03%
1일 변동 폭
$38.58
$39.67
1주일 범위
$34.00
$40.06
52주 변동 폭
$14.63
$43.72
Rigel Pharmaceuticals Stock (RIGL) Company Profile
명칭
Rigel Pharmaceuticals
전화
650-624-1100
주소
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
RIGL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
39.02 | 724.96M | 116.88M | -25.09M | -20.74M | -0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.14 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.49 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.01 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.13 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
371.00 | 41.77B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-05 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-04-03 | 재개 | Piper Sandler | Neutral |
| 2022-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-06-08 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | 개시 | B. Riley Securities | Neutral |
| 2020-11-09 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-11-15 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-09-26 | 재개 | JP Morgan | Overweight |
| 2019-03-01 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-08-27 | 개시 | Citigroup | Buy |
| 2018-05-02 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-12-21 | 재개 | Piper Jaffray | Overweight |
| 2017-12-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-11-06 | 재개 | H.C. Wainwright | Buy |
| 2017-03-09 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-31 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-30 | 재확인 | Piper Jaffray | Overweight |
| 2016-07-13 | 개시 | H.C. Wainwright | Buy |
| 2016-06-13 | 개시 | Piper Jaffray | Overweight |
| 2016-04-22 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2013-04-08 | 재확인 | Stifel | Buy |
| 2012-11-29 | 개시 | UBS | Neutral |
| 2012-11-06 | 재확인 | Oppenheimer | Outperform |
| 2012-03-26 | 개시 | Canaccord Genuity | Hold |
| 2010-12-10 | 다운그레이드 | MP Advisors | Outperform → Market Perform |
모두보기
Rigel Pharmaceuticals 주식(RIGL)의 최신 뉴스
How Rigel Pharmaceuticals Inc. stock performs in high volatility marketsTrade Risk Assessment & Long Hold Capital Preservation Plans - newser.com
What insider trading reveals about Rigel Pharmaceuticals Inc. stockJuly 2025 PreEarnings & Stepwise Trade Execution Plans - newser.com
Can Rigel Pharmaceuticals Inc. (RI2) stock ride next bull market cycleJuly 2025 Recap & Community Verified Trade Signals - newser.com
Will Rigel Pharmaceuticals Inc. (RI2) stock sustain dividend payoutsTrade Analysis Summary & Daily Profit Focused Stock Screening - newser.com
Applying big data sentiment scoring on Rigel Pharmaceuticals Inc.July 2025 Breakouts & Real-Time Volume Analysis - newser.com
How Rigel Pharmaceuticals Inc. stock responds to policy changesJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - newser.com
Can a trend reversal in Rigel Pharmaceuticals Inc. lead to recoveryJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Rigel (Nasdaq: RIGL) to present in London at Jefferies Healthcare Conference - Stock Titan
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35% - simplywall.st
Will earnings trigger a reversal in Rigel Pharmaceuticals Inc.2025 AllTime Highs & Safe Capital Growth Tips - newser.com
Rigel Pharmaceuticals Joins Elite List Of Stocks With 95-Plus Composite Rating - Investor's Business Daily
Will Rigel Pharmaceuticals Inc. stock attract ESG investorsAnalyst Downgrade & Daily Price Action Insights - newser.com
Will Rigel Pharmaceuticals Inc. (RI2) stock split increase liquidity2025 Price Momentum & Reliable Entry Point Trade Alerts - newser.com
Rigel Pharmaceuticals Inc Stock Analysis and ForecastMarket Profile Overview & Low Risk Capital Growth - earlytimes.in
Can Rigel Pharmaceuticals Inc. stock deliver strong Q4 earnings2025 Short Interest & Real-Time Volume Triggers - newser.com
Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance - Yahoo Finance
Will Rigel Pharmaceuticals Inc. stock reach Wall Street targetsWeekly Gains Report & Entry Point Strategy Guides - newser.com
Detecting price anomalies in Rigel Pharmaceuticals Inc. with AIJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com
Candlestick signals on Rigel Pharmaceuticals Inc. stock todayInflation Watch & Weekly Momentum Stock Picks - newser.com
Trading Systems Reacting to (RIGL) Volatility - news.stocktradersdaily.com
Can Rigel Pharmaceuticals Inc. stock hit analyst price targetsPortfolio Value Report & Free Weekly Watchlist of Top Performers - newser.com
What momentum shifts mean for Rigel Pharmaceuticals Inc.Weekly Market Report & Free High Return Stock Watch Alerts - newser.com
Published on: 2025-11-09 21:25:18 - newser.com
Rigel Pharmaceuticals (RIGL): Assessing Valuation Following Record Q3 Results and Raised 2025 Outlook - Yahoo Finance
Measuring Rigel Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Action & Weekly Top Stock Performers List - newser.com
Why Rigel Pharmaceuticals Inc. stock could see breakout soonJuly 2025 PostEarnings & Pattern Based Trade Signal System - newser.com
Published on: 2025-11-09 05:40:52 - newser.com
Published on: 2025-11-09 04:34:19 - newser.com
Is Rigel Pharmaceuticals Inc. stock recession proof2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com
Rigel Pharmaceuticals (RIGL): Valuation Insights After Raised 2025 Guidance and Q3 Performance - simplywall.st
Rigel Pharmaceuticals (RIGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.16%
0.33%
자본화:
|
볼륨(24시간):